Atlas Trials

Comparative Study of Rituximab Versus Combination of Rituximab and Intravenous Cyclophosphamide in Severe Pemphigus

Clinical trial NCT01974518 · UNKNOWN

Trial details

NCT number
NCT01974518
Sponsor
Uprety Shraddha
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Pemphigus
Start date
2013-11-01
Primary completion
2015-06-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.